{
    "title": "Roche aims to 'underwhelm' on SMA drug price to challenge rivals",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7885241/Roche-aims-underwhelm-SMA-drug-price-challenge-rivals.html",
    "date": "2020-01-14",
    "keywords": [
        "drug",
        "price",
        "therapy",
        "year",
        "risdiplam",
        "francisco",
        "gene",
        "treatment",
        "hemlibra",
        "novartis",
        "roche",
        "spinraza",
        "decision",
        "chief",
        "anderson",
        "company",
        "medicine",
        "infusion",
        "trial",
        "jan",
        "drugmaker",
        "atrophy",
        "list",
        "muscle",
        "disease",
        "onetime",
        "thirdtomarket",
        "food",
        "administration",
        "bill",
        "haemophilia",
        "takeda",
        "half",
        "agent",
        "interview",
        "monday",
        "jp",
        "morgan",
        "conference",
        "bleeding",
        "resistance",
        "clotting",
        "factor",
        "choice",
        "sma",
        "development",
        "seller",
        "spine",
        "zolgensma",
        "safety",
        "goahead",
        "researcher",
        "jay",
        "bradner",
        "december",
        "opportunity",
        "molecule",
        "stance",
        "branaplam",
        "study",
        "reporting",
        "robin",
        "respaut",
        "john",
        "miller",
        "editing",
        "fenton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}